?

Mcmullen Michael R.

Director
Bristol-Myers Squibb Company
US, New York [HQ]
CIK 1418949

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
975
Price per Share :
$718.36
Equivalence :
$700,401.00

Transaction History

  • A
    Form 4
    975 Shares After Transaction
    Value : $n/a
    $0.0
    11/06/24
  • Footnotes:
    #1 On November 6, 2024, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 350 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 6, 2025, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA.
    #2 The number of shares of KLA common stock includes 350 shares issuable upon vesting of RSUs.